Deleted Tweets From Scott Gottlieb, R-D.C.
Scott Gottlieb's accounts: SteveFDA
Tracked Between: October 20, 2017-January 20, 2021
SteveFDA (R-D.C.)
@SGottliebFDA
RT @Surgeon_General: Tomorrow is the big day! My #USPHS #CommissionedCorps physical fitness test is here! Thank you all for your support… https://t.co/3JeXjTd3mU
SteveFDA (R-D.C.)
@SGottliebFDA
RT @RAPSorg: When Can @US_FDA 'Refuse to File' NDAs and BLAs? New Draft Guidance Explains | #Regulatory Focus… https://t.co/TjkWPKK0dH
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAOncology: 2017 a banner year for FDA approvals in hematologic malignancies. In this graphic, purple=4 new drug approvals for… https://t.co/TUZCFpeWte
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: #FDA warns companies for promoting alternatives to street drugs: https://t.co/kjTX3Na9U0
SteveFDA (R-D.C.)
@SGottliebFDA
In 2015, 55% of adult smokers made a quit attempt but only 7% were successful. #EveryTryCounts motivates smokers with positive messages to encourage another quit attempt
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: Today #FDA issued guidelines for drug manufacturers regarding labeling for gluten in certain drug products: https://t.co/V00GjjjWKH
SteveFDA (R-D.C.)
@SGottliebFDA
#EveryTryCounts is FDA’s new effort to reduce the public health burden of smoking by encouraging adult smokers to keep trying to quit https://t.co/y0OQN0aeq6 https://t.co/Prq2bHtyM7
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SGottliebFDA: FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient… https://t.co/BpD4nQON5A
SteveFDA (R-D.C.)
@SGottliebFDA
FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient care: https://t.co/8lhBxjBBw1
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAfood: This Friday! Join the expert discussion of results from the #IFSAC report analyzing 2013 outbreak data to estimate… https://t.co/6qyWzy1wA9
SteveFDA (R-D.C.)
@SGottliebFDA
RT @RAPSorg: Generic Drug Monthly Dashboard: @US_FDA Adds New Metrics | #Regulatory Focus https://t.co/LZJ54t91D9 #FDA #genericdrugs #pharma
SteveFDA (R-D.C.)
@SGottliebFDA
RT @SarahKarlin: I chatted with @SGottliebFDA about the drugs of the future. VIDEO: When medicines are as individual as you are https://t.co/uHxRprkiRA
SteveFDA (R-D.C.)
@SGottliebFDA
RT @ManhattanInst: TONIGHT: @SGottliebFDA joins us for a discussion on @US_FDA regulation in the era of precision medicine. Stay tuned… https://t.co/i9NFyFjepF
SteveFDA (R-D.C.)
@SGottliebFDA
RT @ManhattanInst: “We’re trying to put the rules in place to make sure Americans can quickly capitalize on new health technology and… https://t.co/gFeO03OfHd
SteveFDA (R-D.C.)
@SGottliebFDA
RT @mssnytweet: Watch #FDA Commissioner Scott Gottlieb discuss how his agency is adapting to this new era and the regulatory challe… https://t.co/XrOdifTSGc
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDAOncology: Setting the Record Straight on FDA Approvals in Oncology @JAMAInternalMed https://t.co/x76zbYmB1g
SteveFDA (R-D.C.)
@SGottliebFDA
#FDAs new effort to expand information on antibiotic effectiveness, promote better prescribing, reduce antibiotic resistance https://t.co/hzFoCqTOTJ
SteveFDA (R-D.C.)
@SGottliebFDA
RT @FDATobacco: #EveryTryCounts uses ads with positive messages in stores to help adult smokers quit by reframing past quit attempt… https://t.co/bPiUg5nfXL
SteveFDA (R-D.C.)
@SGottliebFDA
Two new #FDA guidances issued today helps targeted therapy developers efficiently create safe and effective individualized treatments that can be targeted with scientifically valid diagnostics https://t.co/KoO7D1FsbB
SteveFDA (R-D.C.)
@SGottliebFDA
#FDA takes new steps to advance targeted approaches to medicines with two, modern frameworks to help ensure we’re providing guidance for efficient development of novel, individualized therapies https://t.co/KoO7D1FsbB